Replay available

Adaptive Biotechnologies Corporation (ADPT) Q2 2023 Earnings Call

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Q2 2023 earnings conference call, held 2023-08-02. Replay captured from the company's public earnings webcast.

Wed, August 2, 2023 at 4:30 PMendedReplay
Adaptive Biotechnologies Corporation (ADPT) Q2 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Nitin Sood

Head of MRD Business

Taika Peterson

Chief Financial Officer

David Westenberg

Analyst, Piper Sandler

Mark Massario

Analyst, BTIG

Derek DeBruyn

Analyst, Bank of America

Karina Calzadilla

Head of Investor Relations

Rachel Vassendahl

Analyst, JPMorgan Chase

Dan Leonard

Analyst, Credit Suisse

Dan Brannon

Analyst, TD Cohen

Chad Robbins

CEO and Co-founder

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Adaptive Biotechnology second quarter 2023 conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1 1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Karina Calzadilla, Head of Investor Relations. Thank you, Jacinda, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnology's second quarter 2023 earnings conference call. Earlier today, we issued a press release reporting adaptive financial results for the second quarter of 2023. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted to the investor section in our corporate website. During the call, management will make projections and other forward-looking statements within the meaning of federal security laws regarding future events and the future financial performance of the company. These statements reflect management's current perspective of the business as of today. Actual results may differ materially from today's forward-looking statement depending on a number of factors which are set forth in our public findings with the SEC and listed in this presentation. In addition, non-GAAP financial measures will be discussed during the call, and a reconciliation from non-GAAP to GAAP metrics can be found in our earnings release. Joining the ...

More from Adaptive Biotechnologies Corporation